Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Davis

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
ACS Chemical Neuroscience|January 18, 2024
Identification of a Novel Subtype-Selective α<sub>1B</sub>-Adrenoceptor AntagonistAlaa Abdul-Ridha, Lazarus A de Zhang, Ashenafi Haileyesus Betrie, et al.
SLAS Discovery : Advancing Life Sciences R & D|September 15, 2023
Multiplexed experimental strategies for fragment library screening against challenging drug targets using SPR biosensorsEdward A FitzGerald, Darius Vagrys, Giulia Opassi, et al.
Global Public Health|April 5, 2023
Aboriginal young people's perspectives and experiences of accessing sexual health services and sex education in Australia: A qualitative studySimon Graham, Kacey Martin, Kristy Gardner, et al.
ACS Omega|January 26, 2026
Targeting PTPN22 at Nonorthosteric Binding SitesA Fragment ApproachPaola Di Lello, Marta M Wells, Ben Davis, et al.
ACS Omega|August 29, 2019
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1James B Murray, James Davidson, Ijen Chen, et al.
Journal of Medicinal Chemistry|July 25, 2019
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular ActivityZoltan Szlávik, Levente Ondi, Márton Csékei, et al.
Bioorganic & Medicinal Chemistry|September 29, 2012
Targeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimizationNicholas G M Davies, Helen Browne, Ben Davis, et al.
Journal of Medicinal Chemistry|July 21, 2009
Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Jenifer Borgognoni, et al.
Journal of Medicinal Chemistry|February 16, 2017
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase KinasePaul A Brough, Lisa Baker, Simon Bedford, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
ACS Chemical Neuroscience|January 18, 2024
Identification of a Novel Subtype-Selective α<sub>1B</sub>-Adrenoceptor AntagonistAlaa Abdul-Ridha, Lazarus A de Zhang, Ashenafi Haileyesus Betrie, et al.
SLAS Discovery : Advancing Life Sciences R & D|September 15, 2023
Multiplexed experimental strategies for fragment library screening against challenging drug targets using SPR biosensorsEdward A FitzGerald, Darius Vagrys, Giulia Opassi, et al.
Global Public Health|April 5, 2023
Aboriginal young people's perspectives and experiences of accessing sexual health services and sex education in Australia: A qualitative studySimon Graham, Kacey Martin, Kristy Gardner, et al.
ACS Omega|January 26, 2026
Targeting PTPN22 at Nonorthosteric Binding SitesA Fragment ApproachPaola Di Lello, Marta M Wells, Ben Davis, et al.
ACS Omega|August 29, 2019
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1James B Murray, James Davidson, Ijen Chen, et al.
Journal of Medicinal Chemistry|July 25, 2019
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular ActivityZoltan Szlávik, Levente Ondi, Márton Csékei, et al.
Bioorganic & Medicinal Chemistry|September 29, 2012
Targeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimizationNicholas G M Davies, Helen Browne, Ben Davis, et al.
Journal of Medicinal Chemistry|July 21, 2009
Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Jenifer Borgognoni, et al.
Journal of Medicinal Chemistry|February 16, 2017
Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate Dehydrogenase KinasePaul A Brough, Lisa Baker, Simon Bedford, et al.
Pageof 9